Search Results - "Shah, Anshul"

Refine Results
  1. 1

    Cost-effectiveness of atrial fibrillation screening in Canadian community practice by Andrade, Jason G., Shah, Anshul, Godin, Richard, Lanitis, Tereza, Kongnakorn, Thitima, Brown, Lauren, Dhanda, Devender, Dhamane, Amol, Nault, Isabelle

    Published in Heart rhythm O2 (01-02-2023)
    “…Contemporary guidelines recommend opportunistic screening for atrial fibrillation (AF). The objective of this study was to assess the cost-effectiveness of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation by Yu, Jingbo, Parasuraman, Shreekant, Shah, Anshul, Weisdorf, Daniel

    Published in Current medical research and opinion (03-06-2019)
    “…Objective: Acute graft-versus-host disease (aGVHD) is a common and life-threatening complication of allogeneic hematopoietic stem cell transplantation…”
    Get full text
    Journal Article
  5. 5

    Bringing Alive Blurred Moments by Purohit, Kuldeep, Shah, Anshul, Rajagopalan, A. N.

    “…We present a solution for the goal of extracting a video from a single motion blurred image to sequentially reconstruct the clear views of a scene as beheld by…”
    Get full text
    Conference Proceeding
  6. 6

    Assessment of clinical and economic impact of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States by Shah, Anshul, Dabbous, Firas, Shah, Surbhi, Ashton, Veronica, Kharat, Akshay

    Published in Journal of medical economics (31-12-2024)
    “…The objective in this study was to assess the clinical and economic implications of the inclusion of rivaroxaban as a secondary prophylaxis in patients with…”
    Get more information
    Journal Article
  7. 7

    Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan by Hernandez, Luis, Kuwabara, Hiroyo, Shah, Anshul, Yamabe, Kaoru, Burnett, Heather, Fahrbach, Kyle, Koufopoulou, Maria, Iwakiri, Ryuichi

    Published in PharmacoEconomics (01-01-2020)
    “…Background Vedolizumab (VDZ) was approved by the Japanese Ministry of Health, Labor and Welfare in 2018 for the treatment of patients with moderate-to-severe…”
    Get full text
    Journal Article
  8. 8

    International Commercial Arbitration in India: Challenges and Opportunities by Shah, Anshul

    Published 01-01-2021
    “…21 years into the 21st Century, we have witnessed everything from booming global economies to apocalyptic pandemics that can threaten to wipe out the entire…”
    Get full text
    Dissertation
  9. 9

    Influence of acute graft-versus-host disease (aGVHD) during allogeneic hematopoietic stem cell transplantation (HSCT) engraftment admission on hospital length of stay (LOS), charges, and costs by Yu, Jingbo, Parasuraman, Shreekant, Shah, Anshul, Narayanan, Siva

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e18544 Background: aGVHD is a common complication of allogeneic HSCT and a significant cause of transplant-related morbidity and mortality…”
    Get full text
    Journal Article
  10. 10

    Use of intermediate clinical endpoints (ICE) as a primary efficacy endpoint in malignant melanoma by Narayanan, Siva, Shao, Dong, Shah, Anshul, Ramesh, Vidya

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e21075 Background: Melanoma incidence in the US has seen a considerable increase, from 17.8 (1997) to 24.0 (2013) per 100,000, with localized…”
    Get full text
    Journal Article
  11. 11

    Pose and Joint-Aware Action Recognition by Shah, Anshul, Mishra, Shlok, Bansal, Ankan, Chen, Jun-Cheng, Chellappa, Rama, Shrivastava, Abhinav

    “…Recent progress on action recognition has mainly focused on RGB and optical flow features. In this paper, we approach the problem of joint-based action…”
    Get full text
    Conference Proceeding
  12. 12

    HaLP: Hallucinating Latent Positives for Skeleton-based Self-Supervised Learning of Actions by Shah, Anshul, Roy, Aniket, Shah, Ketul, Mishra, Shlok, Jacobs, David, Cherian, Anoop, Chellappa, Rama

    “…Supervised learning of skeleton sequence encoders for action recognition has received significant attention in recent times. However, learning such encoders…”
    Get full text
    Conference Proceeding
  13. 13

    Economic Implications of Preventing Major Cardiovascular and Limb Events with Rivaroxaban plus Aspirin in Patients with Coronary or Peripheral Artery Disease in the United States by Hernandez, Luis, Shah, Anshul, Zhao, Qi, Milentijevic, Dejan, Kharat, Akshay

    Published in American health & drug benefits (01-10-2020)
    “…Patients with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD) have increased risks for cardiovascular (CV)-related morbidity and…”
    Get full text
    Journal Article
  14. 14

    Learning Based Single Image Blur Detection and Segmentation by Purohit, Kuldeep, Shah, Anshul B., Rajagopalan, A. N.

    “…This paper addresses the problem of obtaining a blur-based segmentation map from a single image affected by motion or defocus blur. Since traditional…”
    Get full text
    Conference Proceeding
  15. 15

    Multi-View Action Recognition using Contrastive Learning by Shah, Ketul, Shah, Anshul, Lau, Chun Pong, de Melo, Celso M., Chellapp, Rama

    “…In this work, we present a method for RGB-based action recognition using multi-view videos. We present a supervised contrastive learning framework to learn a…”
    Get full text
    Conference Proceeding
  16. 16

    Comparative Safety Analysis of Currently Approved Anti-CD20 Monoclonal Antibodies for First Line Treatment of Chronic Lymphocytic Leukemia (CLL) by Mwamburi, Mkaya, Bal, Vasudha, Cascella, Teresa, Shah, Anshul, Nanavaty, Merena, Gala, Smeet

    Published in Blood (02-12-2016)
    “…Introduction: Treatment of CLL has advanced tremendously in the past decade with significant extension of life expectancy in patients diagnosed with the…”
    Get full text
    Journal Article
  17. 17

    Impact of Dose-Difference in Comparator Arms Among Clinical Trials on Treatment Effect Size in a Network Meta-Analysis: A Case of First-Line Therapies in Chronic Lymphocytic Leukemia (CLL) by Mwamburi, Mkaya, Bal, Vasudha, Cascella, Teresa, Shah, Anshul, Nanavaty, Merena, Gala, Smeet

    Published in Blood (02-12-2016)
    “…Introduction: Network meta-analyses (NMA) are used commonly to allow formal comparisons between drugs that were not compared head-to-head in a clinical trial…”
    Get full text
    Journal Article
  18. 18

    The effect of carbon black and colloidal silica fillers on interfacial adhesion at polystyrene interfaces by Bronner, Mordechai J., Hu, Xuesong, Rafailovich, Miriam, Sokolov, Jonathan, Shah, Anshul A., Kim, Hyun-Joong, Gerspacher, M.

    Published in Journal of adhesion science and technology (01-01-2004)
    “…We have shown that the addition of small amounts of carbon black can drastically reduce the interfacial fracture toughness between polymers. This is…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Budget Impact of Belantamab Mafodotin by Hogea, Cosmina, Maiese, Eric M, Gorsh, Boris, Ambavane, Apoorva, Samyshkin, Yevgeniy, Shah, Anshul, Nikolaou, Andreas, Tosh, Jonathan C, Wang, Feng

    Published in ClinicoEconomics and outcomes research (30-09-2021)
    “…Purpose: Estimate the budget impact of belantamab mafodotin (belamaf) for patients with relapsed/refractory multiple myeloma (RRMM) who have received [greater…”
    Get full text
    Journal Article